Director, Business Development, US West
Crown Bioscience
Summary
The role will be responsible for the development, implementation, and execution of tailored sales strategies to leverage Crown Bioscience's business opportunities in the area of translational science, specifically Oncology.
Job description
Job Summary
The role will be responsible for the development, implementation, and execution of tailored sales strategies to leverage Crown Bioscience's business opportunities in the area of translational science, specifically Oncology.
Responsibilities
- Develop and implement strategic sales plans (short term and long term) to achieve corporate goals in the assigned market
- Identify and analyze business opportunity, and formulate plans to capture the opportunity and deal with problems
- Contact prospective customer/partner companies to further explore business opportunities and manage negotiations
- Develop and maintain key business relationships across a broad sphere of influence, both internally and externally
- Logistics management in daily order
Requirements
- Bachelor Degree in Molecular and Cell Biology or related life science field
- Drug discovery experience selling to biotech – at least 4-5 years of experience
- Relevant business development experience (Biotech, CRO) is required
- Masterful selling skills that result in strong, trusting customer relationships
- Masterful negotiation experience with preferred background knowledge
- Flexibility spending up to 40% travel after pandemic when needed
- Have strong background in oncology and in vivo pharmacology highly desired
Company overview
Crown Bioscience is a global contract research organization (CRO) specializing in oncology and immuno-oncology drug discovery and development. Founded in 2006 and headquartered in San Diego, California, the company operates as a division of JSR Life Sciences. Crown Bioscience provides comprehensive preclinical and translational research services to biotech and pharmaceutical companies, offering innovative solutions across in vivo, in vitro, ex vivo, and in silico platforms. The company is renowned for maintaining the world's largest commercially available patient-derived xenograft (PDX) collection and approximately 1,000 tumor organoid models powered by Hubrecht Organoid Technology. With 11 state-of-the-art facilities across the US, Europe, and APAC, Crown Bioscience delivers integrated services spanning biomarker discovery, translational platforms, and clinical trial support. The company's mission is to accelerate and de-risk drug development, helping clients make faster, more predictive decisions while upholding the highest quality standards through CAP and ISO accreditations.